Disease Info Card

Myotonic Dystrophy

Information about Myotonic Dystrophy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Myotonic Dystrophy

Most recent studies have shown that Myotonic Dystrophy shares some biological mechanisms with ataxia, atrophy, cardiac-arrhythmia, cardiomyopathies, cataract, congenital-myotonic-dystrophy, dystrophia-myotonica-2, dystrophy, fragile-x-syndrome, huntington-disease, muscle-weakness, muscular-atrophy, muscular-dystrophy, myopathy, myotonia-congenita, myotonic-disorders, nervousness, neuromuscular-diseases, trinucleotide-repeat-expansion, weakness.

Among the many pathways, these few ones have gauged particular interests from scientists studying Myotonic Dystrophy, and have been seen in publications frequently: Aging, Cardiac Conduction, Cognition, Dna Repair, Dna Replication, Excretion, Innervation, Insulin Secretion, Localization, Methylation, Mismatch Repair, Muscle Atrophy, Pathogenesis, Reflex, Regeneration, Rna Interference, Rna Processing, Secretion, Translation, Transport

Quite a number of genes have been found to play important roles in Myotonic Dystrophy, such as APOC2, AR, BRD2, CCT3, CDC42BPA, CELF1, CKM, CLCN1, CNBP, DMD, DMPK, GRIP1, HTT, INS, INSR, MAPT, MBNL1, POMC, SIX5. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.